MedPath

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Phase 2
Conditions
HIV Infections
Registration Number
NCT00017992
Lead Sponsor
Triangle Pharmaceuticals
Brief Summary

The purpose of this study is to see if emtricitabine is safe in children infected with HIV and to determine the best dose.

Detailed Description

Children are placed into 1 of 4 treatment groups based on age: Group 1, 3 months to 24 months; Group 2, 25 months to 6 years; Group 3, 7 years to 12 years; Group 4, 13 years to 17 years. They receive baseline evaluations. Antiretroviral-naive patients receive emtricitabine plus stavudine plus lopinavir/ritonavir. Antiretroviral-experienced patients replace lamivudine with emtricitabine. Patients return to the clinic for follow-up visits at Weeks 2 and 4 and then every 4 weeks until Week 48. Safety is evaluated using adverse events, which are reviewed at every clinic visit. Clinical laboratory data and full-profile pharmacokinetics of emtricitabine are evaluated at some visits. After the Week 48 study evaluations are completed, individual patients may continue to receive study medication (as provided by the sponsor) until commercially available, if certain criteria are met.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (14)

USC School of Medicine / LA County Med Ctr

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Univ of Florida Health Science Ctr / Pediatrics

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

Univ of Miami

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Bronx Municipal Hosp Ctr/Jacobi Med Ctr

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

New York Hosp / Cornell Med Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

St Luke's - Roosevelt Hosp Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

State Univ of New York at Stony Brook

πŸ‡ΊπŸ‡Έ

Stony Brook, New York, United States

Saint Jude Children's Research Hosp of Memphis

πŸ‡ΊπŸ‡Έ

Memphis, Tennessee, United States

Fundacion HUES

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

Instituto Mexicano de Investigacion Clinica

πŸ‡²πŸ‡½

Col Roma, Mexico

Scroll for more (4 remaining)
USC School of Medicine / LA County Med Ctr
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.